AwardTape · Defense awards · Glaxosmithkline, LLC
Glaxosmithkline, LLC: $1.7M in DoD and DHS awards
Glaxosmithkline, LLC holds 9 DoD and DHS prime awards with $1.7M obligated Mar 13, 2024 to Apr 23, 2026. Largest category: Drugs and biologicals at $1.7M; largest buyer: Defense Logistics Agency at $1.6M.
| Obligated FY2024+ | $1.7M |
|---|---|
| Awards | 9 |
| FY2024 | $1.7M |
| FY2025 | $33K |
| FY2026 to date | $15K |
| Lifetime obligated on these awards | $2.2M |
| First and latest action | Mar 13, 2024 · Apr 23, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Drugs and biologicals | $1.7M | 8 awards | 99% |
| 2 | Medical equipment and supplies | $15K | 1 awards | 0.9% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Logistics Agency | $1.6M | 3 awards | 91% |
| 2 | Department of the Army | $150K | 4 awards | 8.8% |
| 3 | Office of Procurement Operations | $0 | 2 awards | 0.0% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| SPE2DP24F3249 delivery order | $1.6M | 8510509201 influenza virus vac | Defense Logistics Agency | Drugs and biologicals | Mar 14, 2024 DoD 90d |
| W912LM24FA007 delivery order | $61K | Hepatitis a/b vaccine | Army | Drugs and biologicals | Sep 12, 2024 DoD 90d |
| W901UZ24F0043 delivery order | $42K | Fluarix pfs 24-25 formulation, flu vaccine | Army | Drugs and biologicals | Jun 18, 2024 DoD 90d |
| W901UZ25FA029 delivery order | $33K | 210 boxes fluarix trivalent, influenza vaccine,trivalent (pf),syringe,0.5ml | Army | Drugs and biologicals | Aug 21, 2025 DoD 90d |
| W912L726FA017 delivery order | $15K | Hepatitis a and b vaccines for tennessee ARMY national guard. | Army | Medical equipment and supplies | Apr 23, 2026 DoD 90d |
| SPE2DP24F6223 delivery order | $1.4K | 8510764360 influenza virus vac | Defense Logistics Agency | Drugs and biologicals | Aug 7, 2024 DoD 90d |
| 70RDAD21P00000060 purchase order | $0 | Antiviral medicine (zanamivir - relenza) for the DHS antiviral stockpile | Office of Procurement Operations | Drugs and biologicals | May 10, 2024 |
| HSHQDC15D00016 IDIQ contract | $0 | Igf::ot::igf acquisition of relenza for DHS antiviral stockpile | Office of Procurement Operations | Drugs and biologicals | Jun 20, 2025 |
| SPE2DP24D0005 IDIQ contract | $0 | 4610108702 influenza virus vac | Defense Logistics Agency | Drugs and biologicals | May 21, 2024 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial